Ecuador vs Malaysia: Cause of death, by non-communicable diseases, female
Ecuador
68.9%
in 2021
Malaysia
69.2%
in 2021
Ecuador rank
92nd
Malaysia rank
90th
Cause of death, by non-communicable diseases, female over time
- Ecuador
- Malaysia
How they compare
Malaysia currently reports 69.2% against 68.9% in Ecuador, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Malaysia ahead.
Ecuador ranks 92nd and Malaysia ranks 90th of 185 countries.
Malaysia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.6% | 79.9% | 8.4% | Malaysia |
| 2010s | 79.0% | 79.5% | 0.5% | Malaysia |
| 2020s | 66.4% | 74.8% | 8.4% | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Ecuador or Malaysia?
- Malaysia, at 69.2% against 68.9% in Ecuador as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Ecuador and Malaysia?
- 0.3%, with Malaysia ahead.
- How many years of comparable data are there for Ecuador and Malaysia?
- 6 years are reported by both, from 2000 to 2021.
- How do Ecuador and Malaysia rank globally for cause of death, by non-communicable diseases, female?
- Ecuador ranks 92nd and Malaysia ranks 90th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.